These findings indicate that T-IIA exerts anti-inflammatory effects by disrupting Akt-dependent c-Jun phosphorylation and AP-1 activation, positioning it as a promising modulator of inflammation in rheumatoid arthritis and related conditions [94]. The gene discussed is JUN; the disease is rheumatoid arthritis.